Ledger.Open graph →
SEC Form D · filed August 17, 2023

CytomX Therapeutics, Inc

Offering
$30.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Mani Mohindru · SOUTH SAN FRANCISCO, CADirectorSean Mccarthy · SOUTH SAN FRANCISCO, CAExec · DirectorChris Ogden · Austin, TXExecMarcia Belvin · SOUTH SAN FRANCISCO, CAExecJames Meyers · palm beach, FLDirectorAlan Ashworth · CAMBRIDGE, MADirectorMatthew Young · Chicago, ILDirectorJeff Landau · SOUTH SAN FRANCISCO, CAExecHalley Gilbert · Madison, WIDirectorWayne Chu · SOUTH SAN FRANCISCO, CAExecElaine Jones · Richmond, British Columbia, CanadaDirectorLloyd Rowland · SOUTH SAN FRANCISCO, CAExecChris Ogden · Austin, TXExecMarcia Belvin · SOUTH SAN FRANCISCO, CAExecJames Meyers · SOUTH SAN FRANCISCO, CADirectorAlan Ashworth · CAMBRIDGE, MADirectorMatthew Young · Chicago, ILDirectorJeff Landau · SOUTH SAN FRANCISCO, CAExecHalley Gilbert · Madison, WIDirectorWayne Chu · SOUTH SAN FRANCISCO, CAExecElaine Jones · Austin, TXDirectorMani Mohindru · SOUTH SAN FRANCISCO, CADirectorSean Mccarthy · Cambridge, MAExec · DirectorLloyd Rowland · SOUTH SAN FRANCISCO, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗